Prescription Dermatology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Prescription Dermatology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Transparency Market Research
  • November 2018
  • Pharmaceutical
  • 183 pages

Report Description

1
1

Prescription Dermatology Therapeutics Market - Overview

This report by Transparency Market Research analyzes the global prescription dermatology therapeutics market for the period between 2018 and 2026. An in-depth and unbiased market assessment has been made which offers readers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development, manufacture, and marketing of products prescribed in the treatment of various skin conditions.

The global prescription dermatology therapeutics market has been studied for the forecast period from 2018 to 2026. For research, 2017 has been considered as the base year and 2016 as the historical year. The global prescription dermatology therapeutics market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global prescription dermatology therapeutics market for 2017. The report also provides detailed company profiles of emerging market players operating in the global prescription dermatology therapeutics market.

The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the global prescription dermatology therapeutics market. These factors are likely to aid stakeholders establish a strong foothold in the global prescription dermatology therapeutics market. Furthermore, the market overview section comprises key industry events, pipeline analysis, key mergers & acquisitions across the dermatology industry, epidemiology analysis of the skin diseases, product portfolio overview of leading players, and market attractiveness analysis in the global prescription dermatology therapeutics market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

Scope

The global prescription dermatology therapeutics market has been segmented based product type, distribution channel, and region. In terms of product type, the global market has been classified into acne & rosacea drugs, psoriasis drugs, dermatitis & seborrhea drugs, fungal infection drugs, skin cancer, and others. In terms of distribution channel, the global prescription dermatology therapeutics market has been categorized into hospital pharmacies, retail pharmacies, and mail order pharmacies.

In terms of region, the global prescription dermatology therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, and Australia & New Zealand has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the global market in various regions has been provided in this section.

The report provides a detailed outline/blueprint of the global prescription dermatology therapeutics market which is expected to assist new companies establish their presence and companies to expand their share in the market. The report concludes with the company profiles section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments of key players.

Competitive landscape

Major players operating in the global prescription dermatology therapeutics market include AbbVie, Inc., Janssen Biotech, Inc., Novartis AG, Amgen, Inc., Celgene Corporation, Pfizer, Inc., LEO Pharma A/S, Eli Lilly and Company, Bausch Health Companies, Inc., Sun Pharmaceuticals Ltd., Aclaris Therapeutics, Inc., and Aurobindo Pharma Ltd.

The global prescription dermatology therapeutics market has been segmented into:

Global Prescription Dermatology Therapeutics Market, by Product Type

  • Acne & Rosacea Drugs
  • Psoriasis Drugs
  • Dermatitis & Seborrhea Drugs
  • Fungal Infection Drugs
  • Skin Cancer Drugs
  • Others

Global Prescription Dermatology Therapeutics Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

Global Prescription Dermatology Therapeutics Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Have query on this report?

Make an Enquiry

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Prescription Dermatology Therapeutics Market

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Prescription Dermatology Therapeutics Market Analysis and Forecast, 2016–2026 
4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
5.1.Pipeline Analysis
5.2.Key Mergers & Acquisitions 
5.3.Disease Prevalence & Incidence Rate globally with key countries

Table 01: Global Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 02: Global Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 03: Global Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 04: North America Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 05: North America Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 06: North America Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 07: Europe Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 08: Europe Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product, 2016–2026
Table 09: Europe Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 10: Asia Pacific Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 11: Asia Pacific Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 12: Asia Pacific Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 13: Latin America Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Latin America Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 15: Latin America Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 16: Middle East & Africa Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Middle East & Africa Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product, 2016–2026
Table 18: Middle East & Africa Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074